This content is only available to 2025 ASCRS Annual Meeting physician registrants
To log in, click the teal "Login" button in the upper right-hand corner of this page. If you are logged in but still do not have access, please check your 2025 Annual Meeting registration.
This a case where a nano thin graft of 42 μm was used to revitalize vision. BSCVA 3 months after the surgery was 20/25. Specifically, the descemet membrane was removed from the side port. Using nano thin grafts offers a better visual outcome for the patient by reducing the hypermetropic shift. Nano thin DSEAK offers lesser complication rates and comparable post-operative endothelial cells to DMEK.